Serum SPARC and matrix metalloproteinase-2 and metalloproteinase-9 concentrations after bariatric surgery in obese adults

Obesity Surgery

Volumn 24, Issue 4, 2014, Pages 604-610

  Lee, Yeon Ji ^a   Heo, Yoon Seok ^a   Park, Hye Soon ^b   Lee, Seoung Hee ^b   Lee, Seul Ki ^b   Jang, Yeon Jin ^b  

^a Inha University School of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Bariatric surgery; MMP 2; MMP 9; Serum SPARC concentration

Indexed keywords

ADIPONECTIN; GELATINASE A; GELATINASE B; LEPTIN; OSTEONECTIN; MMP2 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; SPARC PROTEIN, HUMAN;

ADULT; ARTICLE; BARIATRIC SURGERY; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WEIGHT REDUCTION; ADIPOSE TISSUE; BLOOD; INSULIN RESISTANCE; METABOLISM;

ADIPONECTIN; ADIPOSE TISSUE; ADULT; BARIATRIC SURGERY; FEMALE; HUMANS; INSULIN RESISTANCE; LEPTIN; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; OBESITY; OSTEONECTIN; WEIGHT LOSS;

EID: 84898033806     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-013-1111-z     Document Type: Article

References (32)

1. Lee MJ, Wu Y, Fried SK. Adipose tissue remodeling in pathophysiology of obesity. Curr Opin Clin Nutr Metab Care. 2010;13:371-6.
2. Catalan V, Gomez-Ambrosi J, Rodriguez A, et al. Role of extracellular matrix remodelling in adipose tissue pathophysiology: relevance in the development of obesity. Histol Histopathol. 2012;27:1515-28.
3. Chavey C, Boucher J, Monthouel-Kartmann MN, et al. Regulation of secreted protein acidic and rich in cysteine during adipose conversion and adipose tissue hyperplasia. Obesity. 2006;14:1890-7.
4. Kos K, Wong S, Tan B, et al. Regulation of the fibrosis and angiogenesis promoter SPARC/osteonectin in human adipose tissue by weight change, leptin, insulin, and glucose. Diabetes. 2009;58:1780-8.
5. Henegar C, Tordjman J, Achard V, et al. Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol. 2008;9:R14.
6. Sang QX. Complex role of matrix metalloproteinases in angiogenesis. Cell Res. 1998;8:171-7.
7. Croissandeau G, Chretien M, Mbikay M. Involvement of matrix metalloproteinases in the adipose conversion of 3T3-L1 preadipocytes. Biochem J. 2002;364:739-46.
8. Derosa G, Ferrari I, D'Angelo A, et al. Matrix metalloproteinase-2 and -9 levels in obese patients. Endothelium. 2008;15:219-24.
9. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724-37.
10. Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-93.
11. Rao SR. Inflammatory markers and bariatric surgery: a meta-analysis. Inflamm Res. 2012;61:789-807.
12. Yoshizumi T, Nakamura T, Yamane M, et al. Abdominal fat: standardized technique for measurement at CT. Radiology. 1999;211:283-6.
13. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
14. Kos K, Wilding JP. SPARC: a key player in the pathologies associated with obesity and diabetes. Nat Rev Endocrinol. 2010;6:225-35.
15. Wu D, Li L, Yang M, et al. Elevated plasma levels of SPARC in patients with newly diagnosed type 2 diabetes mellitus. Eur J Endocrinol. 2011;165:597-601.
16. Kotani K, Yamada T, Taniguchi N. The association between circulating secreted protein acidic and rich in cysteine (SPARC) and glycosylated haemoglobin (HbA(1c)) during lifestyle-modified weight reduction intervention in obese male subjects. J Int Med Res. 2011;39:528-32.
17. Shiba H, Fujita T, Doi N, et al. Differential effects of various growth factors and cytokines on the syntheses of DNA, type I collagen, laminin, fibronectin, osteonectin/secreted protein, acidic and rich in cysteine (SPARC), and alkaline phosphatase by human pulp cells in culture. J Cell Physiol. 1998;174:194-205.
18. Socha MJ, Manhiani M, Said N, et al. Secreted protein acidic and rich in cysteine deficiency ameliorates renal inflammation and fibrosis in angiotensin hypertension. Am J Pathol. 2007;171:1104-12.
19. Lee SH, Lee JA, Park HS, et al. Associations among SPARC mRNA expression in adipose tissue, serum SPARC concentration, and metabolic parameters in Korean women. Obesity. Epub 2012 Nov 29. PMID: 23666856
20. McCawley LJ, Matrisian LM. Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol. 2001;13:534-40.
21. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 2001;17:463-516.
22. Bouloumie A, Sengenes C, Portolan G, et al. Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. Diabetes. 2001;50:2080-6.
23. Catalan V, Gomez-Ambrosi J, Rodriguez A, et al. Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans. J Mol Med. 2009;87:803-13.
24. de Meijer VE, Sverdlov DY, Le HD, et al. Tissue-specific differences in inflammatory infiltrate and matrix metalloproteinase expression in adipose tissue and liver of mice with diet-induced obesity. Hepatol Res. 2012;42:601-10.
25. Unal R, Yao-Borengasser A, Varma V, et al. Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazone. J Clin Endocrinol Metab. 2010;95:2993-3001.
26. Miksztowicz V, Muzzio ML, Royer M, et al. Increased plasma activity of metalloproteinase 2 in women with metabolic syndrome. Metabolism. 2008;57:1493-6.
27. Cicero AF, Derosa G, Manca M, et al. Vascular remodeling and prothrombotic markers in subjects affected by familial combined hyperlipidemia and/or metabolic syndrome in primary prevention for cardiovascular disease. Endothelium. 2007;14:193-8.
28. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med. 1999;341:738-46.
29. Trengove NJ, Stacey MC, MacAuley S, et al. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen. 1999;7:442-52.
30. Albino FP, Koltz PF, Gusenoff JA. A comparative analysis and systematic review of the wound-healing milieu: implications for body contouring after massive weight loss. Plast Reconstr Surg. 2009;124:1675-82.
31. Ress C, Tschoner A, Ciardi C, et al. Influence of significant weight loss on serum matrix metalloproteinase (MMP)-7 levels. Eur Cytokine Netw. 2010;21:65-70.
32. Laimer M, Kaser S, Kranebitter M, et al. Effect of pronounced weight loss on the nontraditional cardiovascular risk marker matrix metalloproteinase-9 in middle-aged morbidly obese women. Int J Obes. 2005;29:498-501.